Biotech

All Articles

ArsenalBio elevates $325M, rotates off of previous lead property

.Arsenal Biosciences is actually carrying on up. The cell therapy company has added on $325 million ...

Lilly- supported weight loss biotech data IPO

.After raising $170 thousand back in February, metabolic disease-focused BioAge Labs has actually su...

Aelis' cannabis use drug fails period 2b, steering Indivior to reconsider $100M possibility

.Aelis Farma's chances of protecting a simple, favorable choice on a $one hundred thousand alternati...

ProKidney halts period 3 test certainly not required for tissue treatment authorization

.ProKidney has stopped among a set of stage 3 tests for its tissue treatment for renal illness after...

Vaxcyte rises on 'stunning' 31-valent PCV succeed against Pfizer

.Vaxcyte revealed what professionals referred to as "magnificent" stage 1/2 records for its 31-valen...

Recursion's brain condition trial presents little evidence of efficacy

.Recursion has stumbled by means of a very early test of its tech-enabled technique to drug discover...

Acepodia, Pfizer click on all together for chemistry-based tissue therapy

.Phone it an instance of good chemical make up: Acepodia, a biotech based on Nobel Prize-winning sci...

Praxis epilepsy medicine reduces confiscations in period 2 hearing

.Practice Precision Medicines has actually scored yet another midphase succeed in epilepsy this year...

Three directors surrender as Dyne posts combined records for DMD candidate

.After running away a professional hold many years back, Dyne Therapeutics has shown brand new stage...

Arrowhead fires off stage 3 information in unusual metabolic health condition ahead of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its give in front of a prospective face-off along with...